FDA Says Merck & Co., Inc.'s Singulair Data Do Not Suggest Suicide Link
NEW YORK, Jan 13 (Reuters) - U.S. regulators on Tuesday said their review of clinical trials does not suggest Merck & Co's Singulair asthma drug or similar medicines cause suicide or suicidal thought, although the data were inadequate to draw a firm conclusion.